During the past decade, Heart and Vascular Inst. of Texas, PA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Heart and Vascular Inst. of Texas, PA" are "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Heart and Vascular Inst. of Texas, PA" in a lesser frequency.

Most popular intervention types in "Heart and Vascular Inst. of Texas, PA" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Heart and Vascular Inst. of Texas, PA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Heart and Vascular Inst. of Texas, PA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Heart and Vascular Inst. of Texas, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart and Vascular Inst. of Texas, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".